The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 24, 2023
Filed:
Oct. 20, 2021
Applicant:
Alkermes Pharma Ireland Limited, Dublin, IE;
Inventors:
Daniel R. Deaver, Wilmington, NC (US);
Mark Todtenkopf, Franklin, MA (US);
Assignee:
Alkermes Pharma Ireland Limited, Dublin, IE;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/485 (2006.01); A61K 31/439 (2006.01); A61K 31/496 (2006.01); A61K 31/519 (2006.01); A61K 31/5513 (2006.01); A61K 31/554 (2006.01); C07D 221/28 (2006.01); C07D 405/06 (2006.01); A61K 9/20 (2006.01); A61K 31/551 (2006.01);
U.S. Cl.
CPC ...
A61K 31/485 (2013.01); A61K 9/20 (2013.01); A61K 31/439 (2013.01); A61K 31/496 (2013.01); A61K 31/519 (2013.01); A61K 31/551 (2013.01); A61K 31/554 (2013.01); A61K 31/5513 (2013.01); C07D 221/28 (2013.01); C07D 405/06 (2013.01);
Abstract
The present invention relates to the discovery of a novel opioid modulator effective in reducing pharmacologically induced weight gain associated with atypical antipsychotic use. The present invention provides methods of reducing antipsychotic induced weight gain, methods for suppressing food intake and reducing ghrelin levels induced by atypical antipsychotic medications in a patient.